Kumar Dhanasekharan
Chief Tech/Sci/R&D Officer at RENOVACOR, INC.
Profile
Kumar Dhanasekharan is currently the Senior Vice President-Technical Operations at Renovacor, Inc. Previously, he worked as the Vice President-Technical Operations at SwanBio Therapeutics, Inc. He completed his undergraduate degree at the Indian Institute of Technology Madras and his doctorate at Rutgers University, Camden.
Kumar Dhanasekharan active positions
| Companies | Position | Start |
|---|---|---|
| RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | 2021-10-03 |
Former positions of Kumar Dhanasekharan
| Companies | Position | End |
|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Corporate Officer/Principal | - |
Training of Kumar Dhanasekharan
| Indian Institute of Technology Madras | Undergraduate Degree |
| Rutgers University, Camden | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kumar Dhanasekharan